Chemours (CC)
(Delayed Data from NYSE)
$19.57 USD
+0.34 (1.77%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $19.56 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.57 USD
+0.34 (1.77%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $19.56 -0.01 (-0.05%) 7:58 PM ET
5-Strong Sell of 5 5
D Value F Growth A Momentum F VGM
Zacks News
The Zacks Analyst Blog Highlights: Olin, Kronos, Chemours, Tronox and Univar Solutions
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Olin, Kronos, Chemours, Tronox and Univar Solutions
Looking for Earnings Beat? Here Are 5 Top Picks
by Sanghamitra Saha
Top-ranked stocks LULU, AZO, CC, GS and CCRN are likely to beat on earnings and offer investors stellar gains.
Fast-paced Momentum Stock Chemours (CC) Is Still Trading at a Bargain
by Zacks Equity Research
Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Newmont (NEM) Prices Sustainability-Linked Senior Notes Offering
by Zacks Equity Research
Newmont (NEM) projects net proceeds of roughly $992 million from the offering, after deducting discounts and before expenses.
Eastman Chemical (EMN) Amends $1.5 Billion Credit Facility
by Zacks Equity Research
Eastman Chemical's (EMN) amendments include the extension of the existing credit agreement and sustainability-linked pricing terms.
U.S. Chemicals Set for An Upswing in 2022: 5 Top Stocks to Buy
by Anindya Barman
The U.S. chemical industry is poised for an upturn next year on strong end-market demand and an upswing in chemical exports. OLN, KRO, CC, TROX and UNVR are good options for investment right now.
Eastman Chemical (EMN) Raises Quarterly Cash Dividend by 10%
by Zacks Equity Research
Eastman Chemical's (EMN) dividend hike reflects the Board's confidence in its ability to deliver earnings growth and generate strong cash flow.
Best Value Stocks to Buy for December 7th
by Zacks Equity Research
MRBK, FNF, CC, and SIG made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 7, 2021.
Best Income Stocks to Buy for December 7th
by Zacks Equity Research
APTS, CC, BX, and FNF made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 7, 2021.
Best Growth Stocks to Buy for December 7th
by Zacks Equity Research
CC, CPRI, SIG, and CSV made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 7, 2021.
Nucor (NUE) Set to Construct $350 Million Rebar Micro Mill
by Zacks Equity Research
Nucor's (NUE) management approves a rebar micro mill construction in the South Atlantic region with a capex of $350 million.
Univar (UNVR) Buys Sweetmix, Boosts Food Ingredients Portfolio
by Zacks Equity Research
Univar's (UNVR) acquisition of Sweetmix will expand its Brazilian Food Ingredients and CASE portfolio and generate synergies and margin increases.
Nucor (NUE) Raises Regular Quarterly Cash Dividend by 23%
by Zacks Equity Research
Nucor (NUE) increases its regular quarterly cash dividend on its common stock to 50 cents per share.
Newmont (NEM) Announces Guidance for the Longer-Term and 2022
by Zacks Equity Research
Newmont (NEM) expects 2022 attributable gold production of 6.2 million ounces and AISC of $1,050 per ounce at $1,800 gold price.
Chemours (CC) Closes Mining Solutions Unit Sale to Draslovka
by Zacks Equity Research
Chemours (CC) completes Mining Solutions sale and aims to focus on the growth of its main units.
Celanese (CE) Wraps Up Santoprene Elastomers Business Acquisition
by Zacks Equity Research
Celanese's (CE) acquisition broadens the company's portfolio of engineered solutions. The buyout will help it to offer a wider range of functionalized solutions.
Ida Pulls Down US Chemical Output as Supply Chain Woes Linger
by Anindya Barman
The October reading showed lower production on a monthly comparison basis across all regions barring Northeast, reflecting the lingering impacts of Hurricane Ida and supply chain disruptions.
Barrick (GOLD) Announces Distribution for Third $250M Tranche
by Zacks Equity Research
The third tranche of the $750-million return of capital reflects on Barrick's (GOLD) commitment to providing its shareholders with one of the industry's leading returns.
Cleveland-Cliffs (CLF) to Redeem Entire 1.50% Senior Notes
by Zacks Equity Research
Cleveland-Cliffs (CLF) intends to pay 100% of the outstanding principal amount in cash upon the redemption or early conversion of senior convertible notes due 2025.
5 Chemical Growth Stocks to Buy on Industry's Positive Momentum
by Anindya Barman
Strong end-market demand driven by higher industrial activities is expected to help the chemical industry to continue the momentum through this year. CC, OLN, ASIX, MEOH and TROX are worth betting on right now.
Best Growth Stocks to Buy for December 1st
by Zacks Equity Research
ARCB, CSV, and CC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 1, 2021.
Best Value Stocks to Buy for December 1st
by Zacks Equity Research
CC, SBFG, and UFI made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 1, 2021.
New Strong Buy Stocks for December 1st
by Zacks Equity Research
CC, FORR, GFED, HUBG, and JD have been added to the Zacks Rank #1 (Strong Buy) List on December 1st.
Wall Street Analysts Believe Chemours (CC) Could Rally 27%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Chemours (CC) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Ashland (ASH) to Hike Prices of 1,4-Butanediol & Derivatives
by Zacks Equity Research
Ashland (ASH) is increasing the price of 1,4 butanediol by 45 cents per pound.